The VanBrocklin Lab focuses on identifying and validating novel therapeutic targets in melanoma and lung cancer.
c-KIT in melanoma
Acquired vemurafenib resistance in melanoma
RAL in NSCLC
Huntsman Cancer Institute is a National Cancer Institute-Designated Cancer Center and Member of the National Comprehensive Cancer Network